why choose us

First received: June 16, 2025

Clinical Trial: A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Celiac Disease

Study Type: INTERVENTIONAL


Official Title: A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Brief Summary: The goal of this clinical trial is to learn about the safety of a single dose of HB-2121 in adults.It will also look at how the body processes the drug.The main questions it aims to answer are:What side effects do participants have after receiving HB-2121?How much HB-2121 is in the blood over time?Researchers will follow participants for 30 days after receiving HB-2121 to understand how the drug behaves in the body and how safe it is.Participants will:Receive one oral dose of HB-2121Attend 4 in-person clinic…

Read more